Panel Discussion: Promoting Earlier Commercial Discussions to Accelerate the Post-Approval Path to Market

Time: 9:00 am
day: Day Two AM


  • What must be considered when deciphering commercially viable targets for ALS?
  • How can we ensure access to promising, yet expensive, ALS treatments to patients who really need them?
  • Why is it important to assess market viability during the early stages of initial R&D discussions?